NOMAD POWER SOLUTIONS, INC. Debt Conversion, Converted Instrument, Amount
NOMAD POWER SOLUTIONS, INC. (NMAD) reported Debt Conversion, Converted Instrument, Amount of $92.72 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2017-03-29.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2017-03-29
- NOMAD POWER SOLUTIONS, INC. debt conversion, converted instrument, amount for the quarter ending 2015-12-31 was $0.00.
- NOMAD POWER SOLUTIONS, INC. debt conversion, converted instrument, amount for the quarter ending 2015-09-30 was $0.00.
- NOMAD POWER SOLUTIONS, INC. debt conversion, converted instrument, amount for the quarter ending 2015-06-30 was $0.00.
- NOMAD POWER SOLUTIONS, INC. debt conversion, converted instrument, amount for the quarter ending 2015-03-31 was $92.72K.
- NOMAD POWER SOLUTIONS, INC. debt conversion, converted instrument, amount for fiscal 2015 was $92.72K.
| Period end | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-29 | $0.00 derived: sum of 2 quarters · filed 2017-03-29 | $0.00 derived: sum of 3 quarters · filed 2017-03-29 | $92.72K 10-K · filed 2017-03-29 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $0.00 derived: sum of 2 quarters · filed 2015-11-10 | $92.72K 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $92.72K 10-Q · filed 2015-08-07 | ||
| 2015-03-31 | $92.72K 10-Q · filed 2015-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B |